Brief: MGC Pharmaceuticals Secures $7.9 Million In Firm Commitments
Nov 1 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* SECURES US$7.9 MILLION IN FIRM COMMITMENTS
* FUNDS SECURED REPRESENTS MINIMUM AMOUNT REQUIRED TO FUND
MGC
PHARMA'S FULL BUSINESS PLAN OVER NEXT 12-MONTH PERIOD
* PLACEMENT AT ISSUE PRICE OF US$0.255 PER SHARE
Source text for Eikon: ID:nASX7YRjrp
Further company coverage: MXC.AX
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program